Publikationen (28) Publikationen von ANE MIREN GABILONDO URQUIJO

2021

  1. Correction to: Functional approaches to the study of G-protein-coupled receptors in postmortem brain tissue: [35S]GTPγS binding assays combined with immunoprecipitation (Pharmacological Reports, (2021), 73, 4, (1079-1095), 10.1007/s43440-021-00253-z)

    Pharmacological Reports

  2. Functional approaches to the study of G-protein-coupled receptors in postmortem brain tissue: [35S]GTPγS binding assays combined with immunoprecipitation

    Pharmacological Reports, Vol. 73, Núm. 4, pp. 1079-1095

  3. Spinophilin expression in postmortem prefrontal cortex of schizophrenic subjects: Effects of antipsychotic treatment

    European Neuropsychopharmacology, Vol. 42, pp. 12-21

  4. α2A- and α2C-adrenoceptor expression and functionality in postmortem prefrontal cortex of schizophrenia subjects

    European Neuropsychopharmacology, Vol. 52, pp. 3-11

2019

  1. Differential α 2A - and α 2C -adrenoceptor protein expression in presynaptic and postsynaptic density fractions of postmortem human prefrontal cortex

    Journal of Psychopharmacology, Vol. 33, Núm. 2, pp. 244-249

  2. Serotonin 5-HT2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: Selective biased agonism via Gαi1-proteins

    European Neuropsychopharmacology, Vol. 29, Núm. 12, pp. 1453-1463

2016

  1. Alpha2C-adrenoceptor Del322-325 polymorphism and risk of psychiatric disorders: significant association with opiate abuse and dependence

    World Journal of Biological Psychiatry, Vol. 17, Núm. 4, pp. 308-315

2015

  1. Up-regulated 14-3-3β and 14-3-3ζ proteins in prefrontal cortex of subjects with schizophrenia: Effect of psychotropic treatment

    Schizophrenia Research, Vol. 161, Núm. 2-3, pp. 446-451

2014

  1. Increased α2- and β1-adrenoceptor densities in postmortem brain of subjects with depression: Differential effect of antidepressant treatment

    Journal of Affective Disorders, Vol. 167, pp. 343-350

2013

  1. Brain RGS4 and RGS10 protein expression in schizophrenia and depression. Effect of drug treatment

    Psychopharmacology, Vol. 226, Núm. 1, pp. 177-188

2012

  1. Differential regulation of RGS proteins in the prefrontal cortex of short- and long-term human opiate abusers

    Neuropharmacology, Vol. 62, Núm. 2, pp. 1044-1051

  2. HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity

    Nature Neuroscience, Vol. 15, Núm. 9, pp. 1245-1254

2010

  1. Characterization of regulators of G-protein signaling RGS4 and RGS10 proteins in the postmortem human brain

    Neurochemistry International, Vol. 57, Núm. 7, pp. 722-729

2008

  1. Monoamine oxidase B activity is increased in human gliomas

    Neurochemistry International, Vol. 52, Núm. 1, pp. 230-234

  2. PRESENCE OF alpha(2C) DEL322-325 ADRENOCEPTOR GENE POLYMORPHISM IN SUBJECTS WITH DIFFERENT PSYCHIATRIC DISORDERS

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

2006

  1. Synthesis and pharmacological studies of new hybrid derivatives of fentanyl active at the μ-opioid receptor and I2-imidazoline binding sites

    Bioorganic and Medicinal Chemistry, Vol. 14, Núm. 19, pp. 6570-6580

2000

  1. Characterization of receptor-mediated [35S]GTPγS binding to cortical membranes from postmortem human brain

    European Journal of Pharmacology, Vol. 390, Núm. 1-2, pp. 25-36

1999

  1. Differential modulation of α2-adrenoceptor subtypes in rat kidney by chronic desipramine treatment

    Life Sciences, Vol. 64, Núm. 25, pp. 2327-2339

1997

  1. A dileucine motif in the C terminus of the β2-adrenergic receptor is involved in receptor internalization

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 94, Núm. 23, pp. 12285-12290

1996

  1. Mutations of Tyr326 in the β2-adrenoceptor disrupt multiple receptor functions

    European Journal of Pharmacology, Vol. 307, Núm. 2, pp. 243-250